News
Fewer bloodstream infections with FMT for C. difficile
November 4, 2019
Fecal microbiota transplantation for C. difficile infection is associated with fewer bloodstream infections and lower mortality than antibiotics.
News
A sepsis death linked to fecal microbiota transplantation
October 30, 2019
Two patients developed bacteremia after receiving a fecal microbiota transplant from the same donor whose stool contained extended-spectrum beta-lactamase-producing E. coli.
News
How should anticoagulation be managed in a patient with cirrhosis?
October 22, 2019
Patients with chronic liver disease have a risk of VTE similar to (or even greater than) that of general medical patients.
News
Updated international consensus recommendations on management of acute upper GI bleeding
October 21, 2019
Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management.
News
Oral anticoagulant and PPI cotherapy cuts upper GI bleed risk
October 1, 2019
Does proton pump inhibitor (PPI) cotherapy affect the risk of upper GI bleed in patients on oral anticoagulation?
News
Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes
September 16, 2019
High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.
News
Older IBD patients are most at risk of postdischarge VTE
September 10, 2019
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
News
Type of renal dysfunction affects liver cirrhosis mortality risk
September 4, 2019
Patients with acute on chronic kidney disease fared the worst.
News
IV fluid weaning unnecessary after gastroenteritis rehydration
August 6, 2019
SEATTLE – Saving “even a couple hours” to get kids out of the hospital quicker matters.
News
Beyond C. difficile: The future of fecal microbial transplantation
July 29, 2019
SAN DIEGO – Future directions for microbial transplantation range from multifactorial and functional gut disorders to consideration of the small intestinal microbiome.